Harvard Bioscience/HBIO

$4.37

-0.9%
-
1D1W1MYTD1YMAX

About Harvard Bioscience

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. It has organized its product line activities into two product families, cellular and molecular technology (CMT) and Preclinical. Its CMT product family is composed of products supporting research related to molecular, cellular organ and organoid technologies, with additional application in the field of bio-production of pharmaceuticals and therapeutics. Its preclinical product family includes four business lines that support the preclinical research and testing phase for drug development, and in particular testing related to data collection and analysis for safety and regulatory compliance. Its brands include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs and others.

Ticker

HBIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

James Green

Employees

436

Headquarters

Holliston, United States

HBIO Metrics

BasicAdvanced
$188.26M
Market cap
-
P/E ratio
-$0.08
EPS
1.44
Beta
-
Dividend rate

What the Analysts think about HBIO

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
56.29% upside
High $7.00
Low $6.50
$4.37
Current price
$6.83
Average price target

HBIO Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-4.74% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$25.3M
-11.85%
Net income
$-1.2M
33.33%
Profit margin
-4.74%
51.44%

HBIO Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 75%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.04
$0.06
$0.04
$0.01
-
Expected
$0.03
$0.05
$0.06
$0.04
$0.05
Surprise
20%
20%
-36.84%
-75%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Harvard Bioscience stock

Buy or sell Harvard Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing